Medication Harm After an Injury: When Treatment Creates a Secondary Condition

The treatment story can become part of the injury story

An injury claim rarely stands still. Pain, sleep disruption and psychological distress can lead to prescribing; prescribing can lead to dose escalation, interactions and new symptoms. The clinically important question is not simply whether a medicine can cause an adverse effect. It is whether the medication probably contributed to the particular person’s changed condition, function or treatment burden.

A medication-related secondary condition may involve sedation, falls, cognitive slowing, dependence, withdrawal, endocrine effects, sexual dysfunction, gastrointestinal problems, weight change or worsening mood. The original injury may remain the starting point, while treatment becomes an additional causal pathway.

What a causation review needs to test

A defensible opinion should test timing, dose, duration, biological plausibility, competing causes and what happened when treatment changed. It should also distinguish a recognised adverse effect from a clinically significant condition. A product information warning alone does not prove causation in an individual case.

The records that make the difference

Medication histories are often fragmented across general practice, specialists, pharmacies and claim files. Useful records include dispensing histories, medication charts, clinical notes, adverse-event discussions, pathology, specialist reports and contemporaneous descriptions of function. The review should reconcile names, strengths, dates and actual use—not assume every issued prescription was taken exactly as written.

A well-structured chronology often reveals turning points: a sedating medicine introduced before a failed return-to-work attempt; a dose increase before a fall; or antidepressant therapy followed by persistent sexual symptoms that were never actively elicited.

What the final opinion should—and should not—do

A professional report should identify the material relied on, explain the pharmacology in plain language, show where the evidence is strong or uncertain, and answer the referral questions. It should not tell a patient to start, stop or change treatment. Those decisions remain with the treating team.

For lawyers and claimants, the value is clarity: a transparent opinion on whether medication exposure is consistent with the alleged harm, how it may affect recovery and function, what competing explanations remain, and what further evidence could change the conclusion.

Frequently asked questions